Search Within

Caitlin Sarubbi

Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Bone Marrow Transplant (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Hematologic Malignancies, Division of (6)
  5. Survivorship Research (6)
  6. Biostatistics Service (4)

More Groups

People
  1. Heather Landau (6)
  2. Andrew Lin (4)
  3. David Chung (4)
  4. Dean Carlow (4)
  5. Guenther Koehne (4)
  6. Gunjan Shah (4)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2018 (2)
  5. 2017 (2)
Publications
  1. Blood (3)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Amyloid (1)
  4. Bone Marrow Transplantation (1)
Publishers
  1. American Society of Hematology (3)
  2. Elsevier Inc. (2)
  3. Nature Publishing Group (1)
  4. Taylor & Francis Group (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis
    Journal Article

    Muchtar, E.; Dispenzieri, A.; Sanchorawala, V.; Hassan, H.; Mwangi, R.; Maurer, M.; Buadi, F.; Lee, H. C.; Qazilbash, M.; Kin, A.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • A predictive model for day-100 transplant-related mortality in AL amyloidosis
    Meeting Abstract

    Muchtar, E.; Dispenzieri, A.; Sanchorawala, V.; Hassan, H.; Mwangi, R.; Maurer, M.; Lee, H.; Qazilbash, M.; Kin, A.; Zonder, J.; more...
    Amyloid (2024)

    Fulltext@MSK | Save
  • The impact of melphalan conditioning schedule on post-transplant outcomes in AL amyloidosis: A multicenter study with 1718 patients
    Meeting Abstract

    Muchtar, E.; Sanchorawala, V.; Hassan, H.; Hegenbart, U.; Schonland, S.; Lee, H. C.; Qazilbash, M. H.; Kin, A.; Houde, C. A.; Buadi, F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with autologous hematopoietic stem cell transplant (AHCT) for multiple myeloma and AL amyloidosis
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S. J.; Devlin, S. M.; Chung, D. J.; Dahi, P. B.; more...
    Blood (2017)

    Fulltext@MSK | Save